Status Page Transition Complete
As of April 26, 2026, all applicable products have successfully transitioned to a single, consolidated status page to improve service visibility and consistency.
All products are now available at https://status.optum.com, except Pharmacy products, which will transition at a later date. We appreciate your patience as we continue to enhance our status and communication experience.
All Systems Operational
About This Site
If you are experiencing an issue not listed here, please contact Optum support. This site may not reflect status in real time, since status could be delayed.
Absolute AR
Operational
MedRx
Operational
Pharmacy Data Solutions
Operational
Pharmacy Network Solutions
Operational
Pharmacy Software Solutions
Operational
Operational
Degraded Performance
Partial Outage
Major Outage
Maintenance
Scheduled Maintenance
Certificate Information Update Feb 6, 2026 11:45-11:55 EST
Sectigo has recently updated its root and intermediate certificates, including the introduction of the new Sectigo Root R46. To avoid potential service disruption, please ensure your TrustStores are updated with the latest certificates as soon as possible.
As certificate authorities are rotating their roots more frequently, Optum recommends keeping your TrustStores current as part of regular maintenance.
Posted on Feb 06, 2026 - 11:40 EST
As certificate authorities are rotating their roots more frequently, Optum recommends keeping your TrustStores current as part of regular maintenance.
Posted on Feb 06, 2026 - 11:40 EST
Action required: Rx Connect (Switch) and e-Prescribing Mar 1, 2026 00:00-00:10 EST
Customers,
As part of Optum’s effort to continuously improve our systems, we are migrating to Cloudflare to enhance system redundancy, security and cost effectiveness.
This will affect both the network (switch) and e-Prescribing, specifically the following URLs:
• connect.changehealthcare.com
• rxnsconnect.changehealthcare.com
• scriptrouting.changehealthcare.com
• connecthttppost.changehealthcare.com
As part of this change, the DNS names will resolve to the IP Subnet 168.183.3.128 /27 (usable range 168.183.3.128 - 168.183.3.159).
If your firewall filters by DNS, then no action should be needed on your part.
However, if your organization does IP filtering, you will need to add to your whitelist for outbound traffic to IP Subnet 168.183.3.128 /27 (usable range 168.183.3.128-168.183.3.159). This should be completed by March 1, 2026 to avoid disruption when the change is implemented.
Posted on Feb 19, 2026 - 17:30 EST
As part of Optum’s effort to continuously improve our systems, we are migrating to Cloudflare to enhance system redundancy, security and cost effectiveness.
This will affect both the network (switch) and e-Prescribing, specifically the following URLs:
• connect.changehealthcare.com
• rxnsconnect.changehealthcare.com
• scriptrouting.changehealthcare.com
• connecthttppost.changehealthcare.com
As part of this change, the DNS names will resolve to the IP Subnet 168.183.3.128 /27 (usable range 168.183.3.128 - 168.183.3.159).
If your firewall filters by DNS, then no action should be needed on your part.
However, if your organization does IP filtering, you will need to add to your whitelist for outbound traffic to IP Subnet 168.183.3.128 /27 (usable range 168.183.3.128-168.183.3.159). This should be completed by March 1, 2026 to avoid disruption when the change is implemented.
Posted on Feb 19, 2026 - 17:30 EST
Pharmacy Enrollment Reminder Mar 3, 2026 13:00-13:10 EST
Dear Valued Customer,
Effective Feb. 9, 2026, the Pharmacy Enrollment telephone 877-707-0026 will no longer be available.
Action Required: Please be aware the preferred method of communication to the Pharmacy Enrollment team is via email to pharmacyenrollment@optum.com
Contact Us
If you have any questions or concerns, please contact the support team via the online support portal or call directly during business hours.
Pharmacy Support: 866-379-6389
Pharmacy Enrollment: pharmacyenrollment@optum.com
Posted on Mar 03, 2026 - 12:58 EST
Effective Feb. 9, 2026, the Pharmacy Enrollment telephone 877-707-0026 will no longer be available.
Action Required: Please be aware the preferred method of communication to the Pharmacy Enrollment team is via email to pharmacyenrollment@optum.com
Contact Us
If you have any questions or concerns, please contact the support team via the online support portal or call directly during business hours.
Pharmacy Support: 866-379-6389
Pharmacy Enrollment: pharmacyenrollment@optum.com
Posted on Mar 03, 2026 - 12:58 EST
Clarifying KX Modifier for Dispense Fee Issue Mar 4, 2026 18:00-18:10 EST
Optum Insight has identified inconsistent payment activity and reopening outcomes across the DME MACs. As a result, we are temporarily pausing reopening efforts for Recovery clients and recommend that non-Recovery clients who manage their own reopenings do the same at this time.
We are actively conducting claims testing and have engaged the Provider Outreach & Education (POE) team to seek clarification and address our concerns. As a reminder, inhalation claims for Medicare Part B remain on hold in our system pending additional guidance.
Original notice sent Feb. 20, 2026
This message is intended for MedRx Medicare Part B DME Clients
***************UPDATE TO CMS POLICY ON INHALATION HCPCS**************
On 2/1/26 CMS implemented a new policy requiring KX modifier be submitted on inhalation drug claims & the Medicare MedRx system was updated accordingly. Subsequently, on 2/17/26 CMS released an update to this requirement as follows – retroactive for claims date of service 2/1/26 forward:
• In addition to all inhalation HCPCS requiring a KX modifier, the KX modifier must also be submitted on the corresponding dispensing fee claim (one per month per patient).
As CMS has never required a modifier on a dispensing fee claim previously, this policy change will require coding within the Medicare MedRx system to accommodate. As such, we will be putting inhalation drug + dispensing fee claims on hold going forward until such coding can be completed. This will prevent further denials from occurring. We are assessing scope and will provide an updated alert containing delivery timeline soon. Once the coding updates are in place, we will release any held claims to Medicare with the appropriate modifier on both claim lines.
For inhalation claims date of service 2/1/26 – forward which have already been released to Medicare, Medicare is denying the dispensing fee portion of inhalation drug claims while paying the inhalation drug HCPCS. In order to obtain payment for the dispensing fee portion, you will need to take the claims to re-openings.
Action Needed/ How to reopen:
MedRx Recovery customers claims will be worked as part of the standard MedRx Recovery denial management service.
Non-MedRx Recovery customers should perform the following steps:
1. Identify dispensing fee denials with a DOS on or after 2-1-2026 where the drug paid (ANSI denial code CO4).
2. When reopening claims, ensure that the same modifier(s) submitted on the drug is applied to the dispensing fee
Note: All regions handle reopenings via their payer portals, whereas Jurisdictions B and C also take reopenings via fax.
For more information on this policy change, see:
https://cgsmedicare.com/jb/pubs/news/2026/02/cope195982.html
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33370
https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=52466
Posted on Mar 04, 2026 - 17:47 EST
We are actively conducting claims testing and have engaged the Provider Outreach & Education (POE) team to seek clarification and address our concerns. As a reminder, inhalation claims for Medicare Part B remain on hold in our system pending additional guidance.
Original notice sent Feb. 20, 2026
This message is intended for MedRx Medicare Part B DME Clients
***************UPDATE TO CMS POLICY ON INHALATION HCPCS**************
On 2/1/26 CMS implemented a new policy requiring KX modifier be submitted on inhalation drug claims & the Medicare MedRx system was updated accordingly. Subsequently, on 2/17/26 CMS released an update to this requirement as follows – retroactive for claims date of service 2/1/26 forward:
• In addition to all inhalation HCPCS requiring a KX modifier, the KX modifier must also be submitted on the corresponding dispensing fee claim (one per month per patient).
As CMS has never required a modifier on a dispensing fee claim previously, this policy change will require coding within the Medicare MedRx system to accommodate. As such, we will be putting inhalation drug + dispensing fee claims on hold going forward until such coding can be completed. This will prevent further denials from occurring. We are assessing scope and will provide an updated alert containing delivery timeline soon. Once the coding updates are in place, we will release any held claims to Medicare with the appropriate modifier on both claim lines.
For inhalation claims date of service 2/1/26 – forward which have already been released to Medicare, Medicare is denying the dispensing fee portion of inhalation drug claims while paying the inhalation drug HCPCS. In order to obtain payment for the dispensing fee portion, you will need to take the claims to re-openings.
Action Needed/ How to reopen:
MedRx Recovery customers claims will be worked as part of the standard MedRx Recovery denial management service.
Non-MedRx Recovery customers should perform the following steps:
1. Identify dispensing fee denials with a DOS on or after 2-1-2026 where the drug paid (ANSI denial code CO4).
2. When reopening claims, ensure that the same modifier(s) submitted on the drug is applied to the dispensing fee
Note: All regions handle reopenings via their payer portals, whereas Jurisdictions B and C also take reopenings via fax.
For more information on this policy change, see:
https://cgsmedicare.com/jb/pubs/news/2026/02/cope195982.html
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33370
https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=52466
Posted on Mar 04, 2026 - 17:47 EST
Rx Connect (Switch) and e-Prescribing Updated Dates Mar 12, 2026 00:00-00:10 EDT
Customers,
As part of Optum’s effort to continuously improve our systems, we are migrating to Cloudflare to enhance system redundancy, security and cost effectiveness.
This will affect both the network (switch) and e-Prescribing, specifically the following URLs:
• rxnsconnect.changehealthcare.com effective date March 2, 2026
• scriptrouting.changehealthcare.com effective date March 4, 2026
• connecthttppost.changehealthcare.com effective date March 10, 2026
•connect.changehealthcare.com effective date March 12, 2025
As part of this change, the DNS names will resolve to the IP Subnet 168.183.3.128 /27 (usable range 168.183.3.128 - 168.183.3.159).
If your firewall filters by DNS, then no action should be needed on your part.
However, if your organization does IP filtering, you will need to add to your whitelist for outbound traffic to IP Subnet 168.183.3.128 /27 (usable range 168.183.3.128-168.183.3.159).
We asked for this to be completed by March 1, 2026 to avoid disruption when the change is implemented. Above are the effective dates for each connectivity type.
If you have issues please call our customer support team at: 866-379-6389
Posted on Mar 02, 2026 - 17:37 EST
As part of Optum’s effort to continuously improve our systems, we are migrating to Cloudflare to enhance system redundancy, security and cost effectiveness.
This will affect both the network (switch) and e-Prescribing, specifically the following URLs:
• rxnsconnect.changehealthcare.com effective date March 2, 2026
• scriptrouting.changehealthcare.com effective date March 4, 2026
• connecthttppost.changehealthcare.com effective date March 10, 2026
•connect.changehealthcare.com effective date March 12, 2025
As part of this change, the DNS names will resolve to the IP Subnet 168.183.3.128 /27 (usable range 168.183.3.128 - 168.183.3.159).
If your firewall filters by DNS, then no action should be needed on your part.
However, if your organization does IP filtering, you will need to add to your whitelist for outbound traffic to IP Subnet 168.183.3.128 /27 (usable range 168.183.3.128-168.183.3.159).
We asked for this to be completed by March 1, 2026 to avoid disruption when the change is implemented. Above are the effective dates for each connectivity type.
If you have issues please call our customer support team at: 866-379-6389
Posted on Mar 02, 2026 - 17:37 EST
New Pharmacy Support IVR Enhancement Mar 13, 2026 10:00-10:10 EDT
We’re excited to introduce a new enhancement to the Pharmacy Support IVR designed to make claim support faster and more convenient for your pharmacy. When calling for assistance with a claim, you now have the option to use our new automated claim utility, which provides messaging for resolving rejected claims—right within the IVR.
This feature was built with your workflow in mind, offering quick access to common claim responses so you can get the information you need without delay. For more complex needs or personalized support, our knowledgeable customer support representatives remain just a selection away.
By using this new IVR capability, you can reduce wait times, streamline claim resolution, and keep your pharmacy running smoothly. We’re excited to offer this added flexibility and will continue to invest in enhancements that improve your service experience and support your business.
Pharmacy Support
Optum Insight
Posted on Mar 13, 2026 - 09:54 EDT
This feature was built with your workflow in mind, offering quick access to common claim responses so you can get the information you need without delay. For more complex needs or personalized support, our knowledgeable customer support representatives remain just a selection away.
By using this new IVR capability, you can reduce wait times, streamline claim resolution, and keep your pharmacy running smoothly. We’re excited to offer this added flexibility and will continue to invest in enhancements that improve your service experience and support your business.
Pharmacy Support
Optum Insight
Posted on Mar 13, 2026 - 09:54 EDT
Updated Inhalation Meds Announcement Mar 17, 2026 17:45-17:55 EDT
Optum Insight has completed claims testing in collaboration with the Provider Outreach & Education (POE) team to validate payment accuracy and claim reopening outcomes with the new dispense fee modifier. Based on this review, please disregard our former instruction for non-Recovery clients to take related denials to re-openings. We are actively addressing inhalation dispense fee denials for both Recovery & non-Recovery clients which occurred before inhalation claims were placed on hold Feb. 20, 2026. No action is required from providers currently.
System enhancements resulting from this collaborative testing are scheduled for completion by mid-April. At that time, claims that were previously on hold will be released for processing. We appreciate your continued partnership.
Posted on Mar 17, 2026 - 17:43 EDT
System enhancements resulting from this collaborative testing are scheduled for completion by mid-April. At that time, claims that were previously on hold will be released for processing. We appreciate your continued partnership.
Posted on Mar 17, 2026 - 17:43 EDT
Rx Network (Rx Connect/ Rx Edit/ Rx CardFinder, etc.) Maintenance Mar 20, 2026 00:00-06:00 EDT
Optum Insight Rx Network (Rx Connect/ Rx Edit/ Rx CardFinder, etc.) Maintenance Window
• For your awareness, our daily scheduled maintenance window is 12:00 AM-6:00 AM CT.
• During this window, there may be disruptions in connectivity or service availability as maintenance and upgrades are performed.
• Routine deployments that do not cause outages may continue as usual, but all major changes will be scheduled during the maintenance window to minimize impact.
Posted on Feb 20, 2026 - 09:08 EST
• For your awareness, our daily scheduled maintenance window is 12:00 AM-6:00 AM CT.
• During this window, there may be disruptions in connectivity or service availability as maintenance and upgrades are performed.
• Routine deployments that do not cause outages may continue as usual, but all major changes will be scheduled during the maintenance window to minimize impact.
Posted on Feb 20, 2026 - 09:08 EST